NeoLumina
  • Home
  • About us
  • Team
  • Investors
  • Press Releases
  • Blog
  • Contact
Select Page
From Breakthrough to Transformation: Redefining What’s Possible in Mental Health Treatment

From Breakthrough to Transformation: Redefining What’s Possible in Mental Health Treatment

by Admin Neo Lumina | Oct 22, 2025 | News

From Breakthrough to Transformation: Redefining What’s Possible in Mental Health Treatment A single clinical breakthrough changed everything for treatment-resistant depression. Now, NeoLumina is taking that science to a new frontier — applying it to conditions like...
New law to speed study of psychedelics for mental health

New law to speed study of psychedelics for mental health

by Admin Neo Lumina | Oct 21, 2025 | News

New law to speed study of psychedelics for mental health By Clara Harter (Source: Los Angeles Times)Gov. Gavin Newsom recently signed a bill to fast-track the study of psychedelic drugs that hold enormous potential to treat post-traumatic stress disorder and...
Moving Forward with Purpose: NeoLumina Prepares for Phase 2 Clinical Trial in Binge Eating Disorder

Moving Forward with Purpose: NeoLumina Prepares for Phase 2 Clinical Trial in Binge Eating Disorder

by Admin Neo Lumina | Oct 17, 2025 | News

Moving Forward with Purpose: NeoLumina Prepares for Phase 2 Clinical Trial in Binge Eating Disorder NeoLumina BioScience advances its mission to redefine mental health treatment through science, conviction, and collaboration — preparing to launch a Phase 2 clinical...
Breaking the Cycle: A New Path Forward for Eating Disorder Treatment

Breaking the Cycle: A New Path Forward for Eating Disorder Treatment

by Admin Neo Lumina | Oct 14, 2025 | News

Breaking the Cycle: A New Path Forward for Eating Disorder Treatment Eating disorders are complex, deadly, and often intertwined with other physical and mental health challenges. NeoLumina is committed to creating a new way forward — one rooted in nature, science, and...
NeoLumina BioScience Preparing to Begin a Phase 2 Clinical Trial of Innovative Psilocybin-Based Therapy for Binge Eating Disorder

NeoLumina BioScience Preparing to Begin a Phase 2 Clinical Trial of Innovative Psilocybin-Based Therapy for Binge Eating Disorder

by Admin Neo Lumina | Oct 14, 2025 | News

When Science Meets Humanity: A New Era in Treating Eating Disorders Eating disorders are the deadliest of all mental health conditions — but with the right science and the right people, we believe healing is within reach. At NeoLumina BioScience, we don’t just see...
« Older Entries
Designed by NeoLumina Bio